LOADING
Comparing Johnson & Johnson (JNJ) and Bank of America (BAC) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | BAC |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $651.3B | $431.4B |
| P/E Ratio | 31.4 | 14.3 |
| Forward P/E | 23.2 | 13.3 |
| PEG Ratio | 4.73 | 1.05 |
| EPS | $8.62 | $4.33 |
| Revenue Growth (YoY) | 6.6% | 16.8% |
| Profit Margin | 21.5% | 29.5% |
| Return on Equity | 25.7% | 11.2% |
| Dividend Yield | 1.96% | 1.81% |
| Beta | 0.23 | 1.17 |
| 52-Week High | $276.47 | $65.23 |
| 52-Week Low | $170.33 | $45.88 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Bank of America trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Bank of America has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.